SQLite Web: event_store.db

Update row sig_a7aa61339b67 in signals

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1644903/0001437749-26-012392.txt","as_of":"2026-04-16T02:08:52.472606+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1644903/0001437749-26-012392.txt","company":"cbdMD, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1644903/0001437749-26-012392.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_ede00257c8320216","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1644903/0001437749-26-012392.txt","content_type":"text/plain","enriched_at":"2026-04-16T02:11:39.877575+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"ycbd20260415_8k.htm","final_url":"https://www.sec.gov/Archives/edgar/data/1644903/0001437749-26-012392.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1644903/0001437749-26-012392.txt","source_event_id":"evt_47bc23354b98","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"1a130a56fc55fe47","kind":"sec_filing","published_at":"20260415","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-14","2026-04-15","2026-03-31","2026-06-30","2026-09-30","2026-12-31","2027-03-31"],"entities":[{"asset_class":"equity","name":"cbdMD, Inc.","relevance":"high","symbol":"YCBD","type":"issuer"},{"asset_class":"other","name":"NYSE American LLC","relevance":"medium","symbol":"","type":"exchange"},{"asset_class":"other","name":"Board of Directors (the \u201cBoard\u201d)","relevance":"high","symbol":"","type":"governance_body"}],"event_type":"other","information_gaps":["The text does not specify the number of independent directors/non-management employee directors receiving the RSUs (only that each such director received 1,572 RSUs).","No prior-state comparison details are provided in the signal beyond the existence of this 8-K; therefore, the exact change vs prior known state cannot be determined from the provided text alone.","No financial impact, expense recognition, or guidance is quantified in the provided excerpt (only director compensation terms are disclosed)."],"key_facts":["Filing: Form 8-K, Current Report, for cbdMD, Inc.","Date of report / earliest event reported: April 14, 2026.","Item 8.01: Other Events.","On April 14, 2026, the Board issued each independent director and the non-management employee director 1,572 RSUs as compensation for services as a director for the term beginning March 31, 2026.","RSUs vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027.","RSUs were granted under the Company\u2019s 2025 Equity Compensation Plan.","The value of restricted common stock issued is based on the closing price of the common stock as reported by NYSE American LLC on April 14, 2026.","The Board approved annual fees to independent directors: (i) $35,000 annual cash retainer payable monthly for each independent director; (ii) additional $26,500 for the Chairman of the Board; $17,000 for the Chairman of the Audit Committee; $7,000 for the Chairman of the Compensation, Corporate Governance and Nominating Committee; (iii) additional $8,500 to Audit Committee members (excluding chairperson) and $4,000 to Compensation, Corporate Governance and Nominating Committee members (excluding chairperson)."],"numeric_claims":[{"label":"RSUs granted per independent/non-management employee director","value":"1,572"},{"label":"RSU vesting dates","value":"June 30, 2026; September 30, 2026; December 31, 2026; March 31, 2027"},{"label":"Annual cash retainer per independent director","value":"$35,000"},{"label":"Additional annual fee - Chairman of the Board","value":"$26,500"},{"label":"Additional annual fee - Chairman of the Audit Committee","value":"$17,000"},{"label":"Additional annual fee - Chairman of Compensation, Corporate Governance and Nominating Committee","value":"$7,000"},{"label":"Additional annual fee - Audit Committee members (excl. chairperson)","value":"$8,500"},{"label":"Additional annual fee - Compensation, Corporate Governance and Nominating Committee members (excl. chairperson)","value":"$4,000"}],"primary_claim":"On April 14, 2026, cbdMD\u2019s board issued 1,572 restricted stock units to each independent and non-management employee director and approved specified annual director fees.","relevance_score":0.45,"sentiment":"neutral","source_quality":"high","summary":"cbdMD, Inc. filed a Form 8-K reporting board actions on April 14, 2026 regarding director compensation, including RSU grants and annual director fee approvals.","topics":["Form 8-K","director compensation","restricted stock units (RSUs)","equity compensation plan","director fees","vesting schedule"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 cbdMD, Inc. \u00b7 Filed 20260415","ticker":"YCBD","tickers":["YCBD"],"title":"YCBD filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/1644903/0001437749-26-012392.txt"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel